“In oncology today, we are given great opportunities to make a lot of positive impact on the lives of our patients.”

Alexey Danilov, M.D., Ph.D., chose oncology as a career because of its breadth and potential. Oncology, he says, “touches all areas of general medicine” and is a most exciting field because of the many new treatments now emerging.
 
A board-certified clinician and talented researcher, Dr. Danilov focuses on blood cancers, including chronic lymphocytic leukemia and many forms of lymphoma. He is a Leukemia & Lymphoma Society Scholar in Clinical Research.
 
A native of Russia, Dr. Danilov earned his medical degree and Ph.D. at Yaroslavl State Medical Academy. He continued his training with a residency at Brown University in Providence, Rhode Island, and a fellowship at Tufts Medical Center in Boston.

In his role of an Associate Director, Toni Stephenson Lymphoma Center at City of Hope, Dr. Danilov directs an effort in experimental therapeutics in B-cell malignancies. He received peer-reviewed funding from the National Cancer Institute, Leukemia and Lymphoma Society, American Society of Hematology, and Lymphoma Research Foundation, and serves as Translational Medicine Chair of the SWOG Lymphoma Committee, thus participating in drug discovery on a global scale. 

An ideal fit for City of Hope, Dr. Danilov's lab is funded by the National Cancer Institute, Leukemia and Lymphoma Society and American Society of Hematology and concentrates on “bench to bedside” medicine, where preclinical findings lead to early phase clinical trials, ultimately translating into real treatments for real patients.